4Eichhom EJ, Bristow MR. Medical therapy can improve the biological properties of the chronically failing heart [ J ]. Circulation, 1996,94(4) :2285-2296.
5The Task Force of Working Group on Heart Failure of the European Society of Cardiology. The treatment of heart failure[ J]. Eur Heart J,1997,18(5) :736-753.
6ACC/AHA Task Force Report. Guidelies for the evaluation and management of heart failure[ J ]. JACC, 1995,26 (9) : 1376-1398.
5Ohman KP,Karlberg BE.Captopril inhibits angiotensin converting enzyme.New principles for therapy in hypertension and heart failure[J].Lakartidningen,1981,78(45):4039-4041.
6Shi YF,Li DS,Tardif JC,et al.Enalapril effects on atrial remodeling and atrial fibrillation in experimental congestive heart failure[J].Cardiovasc Res,2002,54 (2):456-461.
7Otasevi(c) P,Putinikovi(c) B,Vukajlovi(c) Z,et al.Head-tohead comparison of clinical,biochemical and functional effects of fosinopril and enalapril in patients with systolic heart failure[J].Med Pregl,2006,59 (1/2):51-56.
8Tasi(c) IS,Mijalkovi(c) D,Djordjevi(c) D,et al.Effect of fosinopril on progression of the asymptomatic carotid atherosclerosis and left ventricular hypertrophy in hypertensive patients[J].Srp Arh Celok Lek,2006,134 (3 / 4):106-113.
9Greenbaum R,Zucchelli P,Caspi A,et al.Comparison of the pharmacokinetics of fosinoprilat with enalaprilat and lisinopril in patients with congestive heart failure and chronic renal insufficiency[J].Br J Clin Pharmacol,2000,49(1):23-31.
10Sharma S,Deitchman D,Eni JS,et al.The hemodynamic effects of long-term ACE inhibition with fosinopril in patients with heart failure.Fosinopril Hemodynamics Study Group[J].Am J Ther,1999,6(4):181-189.
